X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. SHASUN PHARMA FDC LTD./
SHASUN PHARMA
 
P/E (TTM) x 24.4 123.9 19.7% View Chart
P/BV x 5.1 8.5 59.5% View Chart
Dividend Yield % 0.9 0.2 399.8%  

Financials

 FDC LTD.   SHASUN PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
SHASUN PHARMA
Mar-14
FDC LTD./
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs14494 152.3%   
Low Rs7946 173.2%   
Sales per share (Unadj.) Rs47.6214.2 22.2%  
Earnings per share (Unadj.) Rs7.65.3 142.6%  
Cash flow per share (Unadj.) Rs9.015.8 57.0%  
Dividends per share (Unadj.) Rs2.251.00 225.0%  
Dividend yield (eoy) %2.01.4 141.4%  
Book value per share (Unadj.) Rs47.553.3 89.1%  
Shares outstanding (eoy) m177.8356.62 314.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.30.3 716.7%   
Avg P/E ratio x14.613.1 111.6%  
P/CF ratio (eoy) x12.34.4 279.4%  
Price / Book Value ratio x2.31.3 178.6%  
Dividend payout %29.618.7 157.8%   
Avg Mkt Cap Rs m19,7843,958 499.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2212,164 56.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,45912,127 69.8%  
Other income Rs m394229 171.6%   
Total revenues Rs m8,85212,356 71.6%   
Gross profit Rs m2,0701,009 205.2%  
Depreciation Rs m249594 42.0%   
Interest Rs m31415 7.5%   
Profit before tax Rs m2,184230 950.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250 74,966.7%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606-73 -832.7%   
Profit after tax Rs m1,353302 447.9%  
Gross profit margin %24.58.3 294.1%  
Effective tax rate %27.7-31.7 -87.6%   
Net profit margin %16.02.5 642.1%  
BALANCE SHEET DATA
Current assets Rs m4,3556,884 63.3%   
Current liabilities Rs m1,7928,456 21.2%   
Net working cap to sales %30.3-13.0 -233.8%  
Current ratio x2.40.8 298.5%  
Inventory Days Days4462 72.1%  
Debtors Days Days25108 22.9%  
Net fixed assets Rs m3,0254,970 60.9%   
Share capital Rs m179113 157.6%   
"Free" reserves Rs m8,2432,875 286.7%   
Net worth Rs m8,4533,020 279.9%   
Long term debt Rs m111,817 0.6%   
Total assets Rs m10,55713,347 79.1%  
Interest coverage x71.41.6 4,597.5%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x0.80.9 88.2%   
Return on assets %13.15.4 244.0%  
Return on equity %16.010.0 160.0%  
Return on capital %23.513.3 176.5%  
Exports to sales %13.346.4 28.7%   
Imports to sales %3.314.2 23.5%   
Exports (fob) Rs m1,1265,622 20.0%   
Imports (cif) Rs m2831,728 16.4%   
Fx inflow Rs m1,1465,843 19.6%   
Fx outflow Rs m3552,173 16.3%   
Net fx Rs m7913,669 21.6%   
CASH FLOW
From Operations Rs m1,485398 373.5%  
From Investments Rs m-620-1,635 37.9%  
From Financial Activity Rs m-7531,309 -57.5%  
Net Cashflow Rs m11371 158.4%  

Share Holding

Indian Promoters % 68.9 39.2 175.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 3.6 130.6%  
FIIs % 7.5 17.6 42.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 39.6 48.0%  
Shareholders   23,730 20,750 114.4%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PANACEA BIOTECH  DISHMAN PHARMA  FULFORD INDIA  NATCO PHARMA  DIVIS LABORATORIES  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 22, 2018 03:33 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - GLENMARK PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS